The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 07, 2014

Filed:

Feb. 19, 2010
Applicants:

Makoto Arita, Tokyo, JP;

Hiroyuki Arai, Tokyo, JP;

Yousuke Isobe, Tokyo, JP;

Ryo Taguchi, Tokyo, JP;

Inventors:

Makoto Arita, Tokyo, JP;

Hiroyuki Arai, Tokyo, JP;

Yousuke Isobe, Tokyo, JP;

Ryo Taguchi, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 59/42 (2006.01); C07C 233/09 (2006.01); A61K 31/16 (2006.01); A61K 31/11 (2006.01); C07C 291/00 (2006.01); C12P 7/64 (2006.01);
U.S. Cl.
CPC ...
C07C 59/42 (2013.01); C12P 7/6436 (2013.01); C12P 7/6427 (2013.01);
Abstract

An object of the present invention is to provide a compound having a novel structure for overcoming the defects of conventional steroid agents and NSAIDs. It is found that the particular dihydroxy bodies of eicosapentaenoic acid and docosahexaenoic acid, which have not conventionally been known (11,18-dihydroxy eicosapentaenoic acid (11,18-diHEPE), 17,18-dihydroxy eicosapentaenoic acid (17,18-diHEPE) etc.), have activity of inhibiting neutrophil, thereby solving the object. The present invention unexpectedly remarkably inhibits infiltration into a tissue of, and activation of neutrophil found out at acute inflammation. The compound of the present invention is a compound which has not conventionally been known. Therefore, utility as a new therapeutic is provided.


Find Patent Forward Citations

Loading…